Neurosterix
eDR32 out of 100, Bottom 25%. Effective DR. Open the scores section.Effective DR: 32/100. Bottom 25%. Measured by StartupHub.ai. Median 68.Agent62 out of 100, Top 25%. Agent Readiness. Open the scores section.Agent Readiness: 62/100. Top 25%. Measured by StartupHub.ai. Median 41.Clinical-stage biotechnology company focused on neuropsychiatric disorders.
About
Clinical-stage biotechnology company focused on neuropsychiatric disorders. Neurosterix is a clinical-stage biotechnology company focused on neuropsychiatric disorders.
Key facts
- Website
- neurosterix.com
- Headquarters
- Geneva, Switzerland
- Employees
- 29
- Total funding
- $168M (Series B)
- Business model
- B2B
Funding rounds
Tech stack
Detected on neurosterix.com, last scanned 12 Nov 2026. Run your own scan
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Integration capability
- Linear
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Neurosterix trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Neurosterix is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Neurosterix raised?
Neurosterix has raised a total of $168M in funding. The most recent round on record is Series B.
How many employees does Neurosterix have?
Neurosterix has approximately 29 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Neurosterix:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
